Europe’s largest commercial cell and gene therapy conference brings together 3,300+ attendees, 300+ speakers, and 200+ exhibitors to advance the field of cell and gene therapies. The two-day event covers the entire ATMP pipeline with content spanning clinical development, manufacturing, regulatory challenges, market access, gene editing, immunotherapy, and patient delivery. Attendees include senior executives from pioneering pharma and biotech companies, researchers, clinicians, academics, regulators, and payers. The congress features multiple conference tracks, an exhibition hall, and extensive networking opportunities focused on driving innovation in advanced therapy medicinal products.

Our team will be onsite so be sure to connect with us during the event or request a meeting today!

Touchlight Attendees